The combination of a dilutive $40M equity raise with accelerating revenue growth and raised guidance creates a mixed signal. The offering provides ~$37.6M net proceeds (after underwriting discounts) that extend the cash runway toward the stated Adj. EBITDA breakeven target by end of 2027, but at the cost of ~15% shareholder dilution. Watch for Q3 2026 full financial results (expected Nov 2026) to confirm whether the preliminary growth trajectory and margin expansion are sustained, and monitor cash burn relative to the improved Free Cash Outflow guidance of <$8M.
Price Chart
Executive Summary
Alpha Teknova priced a $40M underwritten public offering of 8M shares at $5.00/share (closing Oct 22), concurrently disclosed preliminary Q3 2026 revenue of $12.5-12.7M (+19-21% YoY) with gross margin 36-38% and Adj. EBITDA loss of -$1.0 to -$1.2M, and raised full-year 2026 revenue guidance to $45-47M (from $42-44M). The capital raise dilutes existing holders by ~15% but provides runway to reach Adj. EBITDA breakeven by end of 2027, while the preliminary Q3 results show accelerating top-line growth and margin expansion.
Key Financial Metrics
Key Facts
- Priced 8,000,000 share offering at $5.00/share for gross proceeds of $40M; underwriters have 30-day option for 1,200,000 additional shares
- Preliminary Q3 2026 revenue estimated at $12.5M-$12.7M, up 19-21% YoY vs $10.3M in Q3 2025
- Preliminary Q3 2026 gross margin 36-38%, up 500-700 bps YoY from 31% in Q3 2025
- Preliminary Q3 2026 Adj. EBITDA loss of -$1.0M to -$1.2M, improving at least 25% YoY from -$1.6M
- Cash and short-term investments of $16.6M as of Sep 30, 2026; long-term debt of $13.2M as of Mar 31, 2026
- Raised full-year 2026 revenue guidance to $45-47M (from $42-44M), representing ~14% YoY growth at midpoint
- Targeting Adj. EBITDA breakeven quarter before end of 2027; Free Cash Outflow guidance improved to <$8M for 2026
- Lock-up agreements with directors and executive officers through January 19, 2027
- Q2 2026 actuals: revenue $12.2M (+18% YoY), gross margin 40.1%, Adj. EBITDA -$0.7M, EPS -$0.06 (beat consensus of -$0.07 by 14.3%)
Financial Impact
$40M gross proceeds from offering; 8M new shares represent ~15% dilution on ~53.6M pre-offering shares; Q3 preliminary revenue $12.5-12.7M (+19-21% YoY); FY2026 guidance raised to $45-47M
Risk Factors
- Dilution of ~15% from 8M new shares (plus potential 1.2M additional from overallotment) weighs on per-share metrics
- Company remains unprofitable with negative Adj. EBITDA and Free Cash Outflow; breakeven not expected until end of 2027
- Preliminary Q3 results are unaudited estimates subject to change upon completion of financial close
- Proceeds may be used for debt repayment, reducing financial flexibility if growth opportunities arise
- Biotech funding environment remains uncertain; customer orders could be delayed or paused
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-427930 |
| Document: d170994d8k.htm | 0001193125-26-427930 |
| Document: d170994dex993.htm | 0001193125-26-427930 |
| Document: d170994dex992.htm | 0001193125-26-427930 |
| Document: d170994dex991.htm | 0001193125-26-427930 |
| Document: d170994dex51.htm | 0001193125-26-427930 |
| Document: 0001193125-26-427930-index-headers.html | 0001193125-26-427930 |
| Document: 0001193125-26-427930-index.html | 0001193125-26-427930 |
| Document: 0001193125-26-427930.txt | 0001193125-26-427930 |
| 8-K Data (Synthetic) | 0001193125-26-427930 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | Press Release | $6.15 $6.42 | ▲ +4.39% | ▲ +4.91% | $6.59 (+7.15%) |
Oct 21, 2026 4d ago | 8-K | $6.15 $6.42 | ▲ +4.39% | ▲ +4.91% | $6.59 (+7.15%) |
Oct 21, 2026 4d ago | 424B5 | $6.15 $6.42 | ▼ −4.39% | ▼ −4.91% | $6.59 (−7.15%) |
Oct 20, 2026 6d ago | 424B5 | $5.85 $6.15 | ▼ −5.13% | ▼ −6.31% | $6.59 (−12.65%) |
Oct 20, 2026 6d ago | Press Release | $5.85 $6.15 | ▼ −5.13% | ▼ −6.31% | $6.59 (−12.65%) |
Oct 20, 2026 6d ago | Press Release | $5.85 $6.15 | ▲ +5.13% | ▲ +6.31% | $6.59 (+12.65%) |
Jun 1, 2026 20w ago | 8-K | $5.18 $5.13 | ▼ −0.97% | ▼ −0.24% | $6.59 (+27.22%) |
May 6, 2026 24w ago | Press Release | $4.00 $4.00 | · 0.00% | ▼ −0.83% | $6.59 (+64.75%) |
Apr 22, 2026 26w ago | Press Release | $3.03 $3.18 | ▲ +4.95% | ▲ +4.17% | $6.59 (+117.49%) |
Mar 6, 2026 33w ago | Insider Cluster | $2.11 $2.12 | ▲ +0.47% | ▼ −0.37% | $6.59 (+212.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers